Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non–Small-Cell Lung Cancer
Roy S. Herbst, Margarita Majem, Fabrice Barlési, Enric Carcereny, Quincy Siu-Chung Chu, I. Monnet and 10 more
- Rank
- 35 of 548
- Percentile
- top 6.4%
- Where
- Journal of Clinical Oncology, 2022
- Citations
- 320
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.